Super charging the mitochondria and this is already approved for Bart's disease along heart disease and other health issues.

We will discuss the Dalton rate and everything in between.

FST-344: Scientific Foundations and Therapeutic Potential that can unlock unlimited potential

Tesofensine the dementia possibility drug turns into a weight loss product!

Let's talk about hype.and science for tb500

An evidence-based breakdown of Thymosin Alpha-1 (TA-1) covering immune mechanisms, preclinical research, human clinical trials, safety data, and ongoing studies in infection, sepsis, and cancer.

This episode is designed for listeners interested in clinical research, peptide science, endocrinology, and translational medicine, offering an evidence-based perspective without speculation or medical advice.

Topics include:

• Tesamorelin peptide mechanism of action
• Preclinical and animal studies
• Phase II and Phase III clinical trial data
• FDA approval and HIV-associated lipodystrophy
• Growth hormone, IGF-1, and metabolic effects
• Safety, limitations, and ongoing research

This episode is designed for listeners interested in clinical research, peptide science, endocrinology, and translational medicine, offering an evidence-based perspective without speculation or medical advice.

Topics include:

• Tesamorelin peptide mechanism of action
• Preclinical and animal studies
• Phase II and Phase III clinical trial data
• FDA approval and HIV-associated lipodystrophy
• Growth hormone, IGF-1, and metabolic effects
• Safety, limitations, and ongoing research

In this episode, we deliver an in-depth, evidence-based discussion on the MOTS-c peptide, a mitochondria-derived peptide that has gained significant attention in metabolic health, insulin sensitivity, exercise performance, and longevity research. MOTS-c is unique among peptides because it is encoded by mitochondrial DNA and functions as a key regulator of cellular energy metabolism and stress adaptation.

This podcast explores how MOTS-c works at the cellular level, its role in activating AMPK pathways, regulating glucose utilization, and supporting mitochondrial resilience. We examine preclinical and emerging human research on MOTS-c’s potential impact on metabolic syndrome, age-related decline, obesity, inflammation, and exercise capacity, while clearly distinguishing established science from ongoing investigation.

Human Chorionic Gonadotropin (hCG) is one of the most discussed—and misunderstood—peptides in hormone optimization, metabolic health, and weight management. In this in-depth podcast episode, we break down the science of the hCG peptide, exploring its mechanism of action, clinical research, hormonal effects, and proposed fat-loss applications.

This episode examines peer-reviewed clinical data, expert peptide commentary, and historical medical use of hCG in endocrinology, fertility medicine, hypogonadism, and metabolic regulation. We also address common myths surrounding hCG injections and hCG diet protocols, separating marketing claims from evidence-based medicine.